Personalized End-of-Life Care in Safety-Net Hospitals
Personalized End of Life Care in Safety-Net hospitals: Implementation of the 3 Wishes Project
This initiative brings a special program called the 3 Wishes to safety-net hospitals to help critically ill patients and their families have a more peaceful and compassionate end-of-life experience.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11090552 on NIH RePORTER |
What this research studies
For patients and families facing the end of life in safety-net hospitals, it can be especially challenging to feel fully supported due to hospital budget limits and communication difficulties. This program, called the 3 Wishes, helps hospital teams identify and fulfill small, meaningful wishes for patients who are dying in the intensive care unit. The goal is to create a more dignified and caring experience for patients and to provide comfort to their families during a very difficult time. By focusing on personalized care, we hope to make a significant difference in how end-of-life care is provided in these important community hospitals.
Who could benefit from this research
Good fit: This program is designed for critically ill patients who are dying in intensive care units within safety-net hospitals and their families.
Not a fit: Patients who are not critically ill, are not nearing the end of life, or are not receiving care in a safety-net hospital would not directly benefit from this specific program.
Why it matters
Potential benefit: If successful, this program could provide a more dignified and compassionate end-of-life experience for patients and help ease the grief for their families.
How similar studies have performed: The 3 Wishes Project has previously shown success in improving family experiences and clinician satisfaction in academic medical centers.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Neville, Thanh H — University of California Los Angeles
- Study coordinator: Neville, Thanh H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.